Preventing Alzheimer's Before Symptoms Emerge: A Tipping Point? The latest development in the fight against Alzheimer's disease has sparked excitement and caution.
The PrevenTRON study, led by the Surrey and Borders Partnership NHS trust, aims to investigate whether prescribing Trontinemab can prevent dementia from developing in people without symptoms.
This trial marks a significant shift in research focus – from treating Alzheimer's after symptoms appear to actively preventing its onset.